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Methamphetamine (MA) consumption causes disruption of many biological rhythms
including the sleep-wake cycle. This circadian effect is seen shortly following MA
exposure and later in life following developmental MA exposure. MA phase shifts,
entrains the circadian clock and can also alter the entraining effect of light by currently
unknown mechanisms. We analyzed and compared immunoreactivity of the immediate
early gene c-Fos, a marker of neuronal activity, to assess neuronal activation 2 h
following MA exposure in the light and dark phases. We used network analyses of
correlation patterns derived from global brain immunoreactivity patterns of c-Fos, to
infer functional connectivity between brain regions. There were five distinct patterns of
neuronal activation. In several brain areas, neuronal activation following exposure to MA
was stronger in the light than the dark phase, highlighting the importance of considering
circadian periods of increased effects of MA in defining experimental conditions and
understanding the mechanisms underlying detrimental effects of MA exposure to brain
function. Functional connectivity between the ventromedial hypothalamus (VMH) and
other brain areas, including the paraventricular nucleus of the hypothalamus and
basolateral and medial amygdala, was enhanced following MA exposure, suggesting
a role for the VMH in the effects of MA on the brain.
Keywords: methamphetamine, light phase, dark phase, activation, functional connectivity
Introduction
The abuse of the psychostimulant methamphetamine (MA) causes great physiological (Wolkoff,
1997), social (Sommers et al., 2006), and financial damage (Dobkin and Nicosia, 2009). It is
estimated to cost the United States approximately $23.4 billion annually (Dobkin and Nicosia,
2009). In the United States, MA was abused by approximately 439,000 people in 2011, 133,000
of which were new users (SAMHSA 2012).
MA consumption by humans is characterized by disruption of many biological rhythms
including the sleep-wake cycle (Hasler et al., 2012). This circadian effect is not only seen relatively
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shortly following MA exposure (Honma et al., 1986, 1991;
Uchihashi et al., 1994; Masubuchi et al., 2001; Olsen et al.,
2013), but also later in life following developmental MA exposure
(Eastwood et al., 2012). MA phase shifts, entrains the circadian
clock, and can also alter the entraining effect of light by
currently unknown mechanisms (Honma et al., 1986). The
circadian rhythms of mice or rats made arrhythmic by lesions
of the suprachiasmatic nucleus (SCN) can be regenerated by
consumption of MA dissolved in the drinking water (Honma
et al., 1986; Tataroglu et al., 2006; Mohawk et al., 2009). These
reconstituted rhythms are robust and show periods significantly
longer than the wild-type rhythms. These observations led
to the hypothesis that a separate MethAmphetamine-Sensitive
Circadian Oscillator (MASCO) exists in the brain separate from
the SCN (Tataroglu et al., 2006). The MASCO is not composed
of the canonical clock genes since animals made arrhythmic
by knocking out these clock genes continue to demonstrate
robust MA-induced rhythms (Masubuchi et al., 2001; Mohawk
et al., 2009). To date, the location of this oscillator and its
molecular make up remain completely unknown (Tataroglu
et al., 2006). Although the SCN might play a role in MASCO,
it does not seem critical as the effects of MA on circadian
system are also seen in animals in which the SCN is lesioned
(Tataroglu et al., 2006).
The ventromedial hypothalamus (VMH) might play a role
in the circadian effects of MA. The VMH is involved in
synchronization of rhythms to periodic feeding but, unlike the
SCN, does not contain a self-sustained oscillator associated with
food (Inouye, 1983). The VMH is also important for circadian
rhythms in serum insulin, glucose, and triglycerides (Egawa et al.,
1993). Disturbed circadian feeding rhythmicity and inhibition of
the glucose preference reversal are observed in rats with VMH
lesions, a functional state similar to that seen following chronic
MA exposure (Kraeuchi et al., 1985; Mitsushima et al., 1994).
The VMH might be involved in other circadian rhythms as well.
Implantation of a hydro-polymer gel into the VMH to alter its
neural network, likely involving neural output via a dorsal route,
showed attenuation of circadian activity levels in blind female rats
and of circadian changes in serum melatonin levels (Mitsushima
et al., 1994).
The adrenocorticotropic hormone (ACTH) secretagogue
arginine vasopressin (AVP) (Dornhorst et al., 1981; Antoni, 1986)
plays a role in circadian effects. Intrahypothalamic injection of an
AVP V1 receptor blocker reveals the diurnal stimulatory input of
AVP to Hypothalamus-Pituitary-Adrenal (HPA) axis activation
(Kalsbeek et al., 1996). Release of AVP in the paraventricular
nucleus of the hypothalamus (PVN) is also seen following
emotional stress (Wotjak et al., 1996), local inflammation
(Turnbull and Rivier, 1996), and inflammatory cytokines (Raber
et al., 1998). The PVN showed profound activation by MA and
an increase in the number of c-Fos/AVP dual-labeled cells during
the light phase (Zuloaga et al., 2014). It is unclear whether these
effects are restricted to the light phase or seen in the dark phase
as well.
In most studies, there is a bias to study a particular brain
region or network that is pertinent to a specific behavioral or
cognitive change seen following MA exposure or other drugs of
abuse (Abekawa et al., 1996; Broening et al., 1997; Chang et al.,
2002, 2004, 2009; Brady et al., 2003; Koob and Volkov, 2010). In
the current study, we analyzed and compared immunoreactivity
of the immediate early gene c-Fos, a marker of neuronal activity
(French and Pavlidis, 2011), to assess neuronal activation 2 h
following MA exposure in the light and dark phases. We also
compared co-localization of c-Fos with AVP in the PVN in
the light and dark phases. Finally, we used network analyses of
functional connectivity based on global brain immunoreactivity
patterns of c-Fos, to infer functional connectivity between brain
regions (Schiltz et al., 2007). We hypothesize that a brain region
showing a neuronal activation pattern in the light and dark
phases that resembles that of the SCN and shows a functional
neuronal connectivity that is enhanced following MA exposure
might suggest its involvement in MASCO.
Materials and Methods
Animals
Forty male C57BL6/J mice, 28–42 days old, were purchased from
JAX Laboratories (Bar Harbor,Maine) andmaintained on a 12/12
light/dark cycle with lights on at 5:00 am (Zeitgeber Time 0, ZT0).
Mice were singly housed for 4 days prior to experiments and were
between 50 and 70 days old at the time of testing. Rodent chow
(PicoLab Rodent Diet 20, #5053; PMI Nutrition International, St.
Louis, MO) and water were available ad libitum.
Animal Approval
All procedures complied with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals
and with IACUC approval at Oregon Health & Sciences
University.
MA Treatment and c-Fos Immunohistochemistry
The mice were injected with (d)-MA hydrochloride dissolved
in saline (1mg/kg, ip.) or saline alone between 3 and 4 h after
lights on (ZT3–4) or 3–4 h after lights off (ZT15–16). Two
hours later, the mice were intracardially perfused with 20ml
of phosphate buffered saline (PBS), followed by 40ml of a 4%
paraformaldehyde solution. Brains were removed, stored in 4%
paraformaldehyde overnight, and then transferred to a 30%
sucrose solution. The 2 h time point was chosen based on our
previous study that demonstrated extensive c-Fos induction in
the mouse brain following administration of the same dose
of MA (Zuloaga et al., 2014). The mice were injected and
perfused in separate cohorts so that all mice in a cohort
were perfused within 82min. Fixed brains were coronally
sectioned at 40µm into three series using a cryostat (Microm
HM505E, MICROM international GmbH, Walldorf, Germany)
and processed for immunohistochemical detection of c-Fos.
Sections were rinsed in PBS, incubated in 1% hydrogen peroxide
and 0.3% Triton-X in PBS (PBS-TX) for 10min, again rinsed
in PBS, then incubated in 10% normal goat serum (NGS) in
PBS-TX for 1 h. After rinsing in PBS, sections were incubated
in primary antisera (c-Fos rabbit polyclonal: 1:5000, Santa
Cruz Biotechnology, sc52) in 4% NGS and PBS-TX overnight
at room temperature. Sections were then rinsed in PBS and
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incubated for 1 h in biotinylated goat-anti rabbit antibody in PBS-
TX (1:500, Vector Laboratories, Burlingame, CA), followed by
rinses in PBS and a 1 h incubation in avidin-biotin peroxidase
complex (ABC Elite kit, Vector Laboratories, Burlingame, CA).
Following rinses in Tris buffered saline (TBS), sections were
developed for visualization of c-Fos positive cells in a hydrogen
peroxide/diaminobenzidine/TBS solution for 10min, after which
sections were rinsed in PBS and immediately mounted on slides.
The following day, sections were dehydrated in ethanol, defatted
in xylene, and coverslipped with Permount (Sigma Chemical Co.,
St. Louis MO).
Dual Label Immunohistochemistry
To determine the co-localization of c-Fos and AVP
immunoreactivity in the mouse brain, we performed dual
label immunohistochemistry. Free-floating sections were rinsed
with PBS 3 times, then blocked with 4% donkey serum in
PBS-TX for 90min. Sections were then incubated in anti-c-Fos
(1:250, goat, Santa Cruz Biotechnology, sc52-G, Billerica, MA)
overnight. Sections were then incubated in 1:200 donkey anti-
goat Dylight 594 (Abcam, Cambridge, MA, USA) for 3 h at room
temperature. Sections were then rinsed in PBS 4 times (20min
each rinse) after which the same protocol was repeated using AVP
(1:500, rabbit, gift from Dr. Paul Plotsky) as primary antibody
and 1:200 donkey anti-rabbit Alexa 488 (Life Technologies)
as the secondary antibody. Sections were slide mounted and
coverslipped with antifade reagent to preserve fluorescent signal
(Vectashield with DAPI, Vector), light protected, and stored
at 4◦C.
Microscopy
Quantification of c-Fos positive cells was performed using
an Olympus IX81 microscope (Olympus, Center Valley, PA,
USA) equipped with Slidebook software (Intelligent Imaging
Innovations, Inc., Denver, CO, USA). Images of discrete brain
regions were captured bilaterally within two sections using a
10× objective. These regions were mainly selected based on
our previous study showing robust neuronal activation in these
areas following MA exposure during the light phase (Zuloaga
et al., 2014). Regions were identified using the mouse brain
atlas (Franklin and Paxinos, 1997). c-Fos immunoreactive cells
(identified by black nuclear label) were quantified bilaterally
within fixed area frames; infralimbic cortex (ILC; Bregma
1.94–1.78; box, 580 × 520µm), SCN (Bregma -0.82 to -0.94;
740 × 420µm), PVN (Bregma -0.82 to -0.94; box, 275 ×
450µm), paraventricular thalamic nucleus (PVT; Bregma −0.82
to −0.94; box, 790 × 410µm each), bed nucleus of the
stria terminalis (BNST; Bregma 0.02 to −0.10; box, 335 ×
620µm), central amygdala (CEA; Bregma −1.34 to −1.46;
circle, 575µm diameter), basolateral amygdala (BLA; Bregma
−1.34 to −1.46; circle, 450µm diameter), medial amygdala
(MEA; Bregma 0.02 to −0.10; box, 460 × 400µm), cingulate
cortex area 2 (CIN; Bregma −1.34 to −1.46; box, 428.28 ×
394.74µm), nucleus accumbens core (NACc; Bregma 1.1–
0.98; circle, 652.74µm in diameter), nucleus accumbens shell
(NACs; Bregma 1.1–0.98, box, 300 × 350µm), arcuate nucleus
(ARC; Bregma −1.46 to −1.58; right triangle, 420 × 380µm),
VMH (Bregma −1.46 to −1.58; circle, 380µm diameter),
dorsomedial hypothalamus (DMH; Bregma −1.46 to −1.58;
440 × 550µm), dentate gyrus (DG; Bregma -0.82 to -0.94;
box, 850 × 420µm), CA1 region of the hippocampus (CA1;
Bregma −0.82 to −0.94; box, 850 × 420µm), and CA3 region
of the hippocampus (CA3; Bregma −0.82 to −0.94; box, 850 ×
420µm).
For quantification of c-Fos/AVP dual labeling, confocal
images of the PVN were captured bilaterally at 20× in two
sections using the same Olympus IX81 confocal microscope. c-
Fos/AVP dual-labeled cells were quantified within two regions
of the PVN, the lateral magnocellular (circle, 135µm diameter)
and the medial parvocellular regions (circle, 135µm diameter).
Cells were considered co-localized when they expressed both
red (c-Fos) and green (AVP) fluorescence. For AVP/c-fos co-
expressing cells AVP was found within the extra-nuclear area,
while c-fos was localized to the nucleus, resulting in a green cell
body that surrounds a red nucleus. The number of c-Fos/AVP
expressing cells in the magnocellular and parvocellular regions
were counted within each brain and the data are expressed as
the mean number of c-Fos/AVP positive cells per experimental
group.
Functional Connectivity Analysis
Using the c-Fos immunohistochemical data (single labeling with
biotinylated secondary antibody), we inferred a measure of
functional connectivity between brain regions, following the
general methodology introduced by Schiltz et al. (2007). We
based our analysis on the average number of activated cells in
each brain. These values were correlated across samples, and
significant correlations were considered evidence of functional
connectivity or coupling between the respective brain regions.
These values were correlated across samples, and significant
correlations were considered evidence of functional connectivity
or coupling between the respective brain regions. As there was
no interaction between time of day and MA treatment, we
collapsed the data of the light and dark phases for the connectivity
analysis. Combining the data from the light and dark phases also
increased the power of the analysis. To examine the effects of MA
exposure on functional connectivity, we quantified the functional
connectivity between the regions for animals exposed to MA
vs. saline controls. We correlated the relative activation levels of
each brain region across individuals/samples and we considered
TABLE 1 | Patterns of neuronal activity.
Pattern Treatment Time effect Treatment × Brain
effect Time areas
interaction
1 Yes No No ILC, CEA, BNST,
CA1, CIN, NACc
2 No Yes No SCN, VMH, DMH
3 Yes No, only yes
in PVN
Yes PVN, PVT, ARC
4 Yes Yes No CA3, NACs
5 No No No MEA, BLA, DG
Frontiers in Neuroscience | www.frontiersin.org 3 September 2015 | Volume 9 | Article 326
Zuloaga et al. Methamphetamine and the ventromedial hypothalamus
thesemeasures to reflect the levels of functional coupling between
distinct brain regions. For each region, the sum of absolute
levels of correlations with all other regions was denoted as the
connectivity. To determine whether these connectivity values
could arise by chance, we employed a permutation procedure.
We randomized the order of the samples and recomputed
the correlations, with the expectation that correlation values
and consequently connectivity values that arise from chance
randomized sample orders will be significantly lower than the
values inferred from the unperturbed data.We divided the data in
two sets of MA exposed and saline exposed animals, respectively,
and we constructed networks from these two groups. In these
separate networks, we observed differences in connectivity values
of brain regions. To evaluate whether these changes reach
statistical significance, we employed a bootstrapping procedure
utilized in comparing MRI-derived functional connectivity
networks (Hosseini and Gat, 2012), as well as in comparing gene
co-expression networks (Gill et al., 2014). We combined the MA
exposed and saline exposed data and we separated the combined
data in two sets (n = 10,000 random resamples); for each of
these resamples we constructed two different networks and we
recorded the difference in connectivity. The difference between
the MA exposed and saline exposed networks was compared
to the distribution of differences arising from mixed-sample
networks.
Statistical Analyses
All data are reported as means ± standard error of the mean
(SEM). Data were analyzed using GraphPad Prism v.4 and SPSS
v.16.0 software (Chicago, IL). Immunohistochemical data were
analyzed using Two-Way ANOVA with time and treatment
as factors. For the functional connectivity analyses, R software
was used. Bonferroni corrected post hoc comparisons were
performed when statistically appropriate. Using a bootstrapping
procedure, we derived statistical significance for changes in the
patterns of connectivity.
Results
c-Fos Quantification
For each brain area, we analyzed whether there were significant
effects of treatment, time of day, and a treatment × time
interaction. In brain areas in which there was a time× treatment
interaction, we also analyzed the effects of the two treatments
(i.e., MA and saline) separately. Based on the statistical analysis,
there were five distinct patterns of neuronal activation: (1) brain
areas that showed an effect of treatment, but no effect of time
or time × treatment interaction: (2) brain areas that showed an
effect of time, but no effect of treatment or time × treatment
interaction; (3) brain areas that showed an effect of treatment
and a treatment × time interaction; (4) brain areas that showed
FIGURE 1 | Brain areas that showed only an effect of treatment. Following MA exposure, there was an increase in c-Fos immuno-positive cells in the ILC (A),
CEA (B), BNST (C), CA1 (D), CIN (E), and NACc (F). Representative images for neuronal activation in the CEA following saline or MA exposure in the day (AM) and
night (PM) are shown in (G). n = 10 mice/treatment/time period.
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effects of treatment and time but no time× treatment interaction;
and (5) brain areas that show no effects of treatment or time
and no time × treatment interaction. Each pattern is described
separately below. Please see also Table 1 for an overview of the
statistical effects.
Pattern 1. Brain Areas That Showed Only an
Effect of Treatment
Six brain regions showed an overall increase in c-Fos positive cells
following MA treatment in the light and dark phases (Figure 1).
There was a significant main effect of MA for the number
of c-Fos immunopositive cells in the ILC [F(1, 36) = 14.19,
p = 0.014; Figure 1A), CEA [F(1, 36) = 90.17, p < 0.001;
Figure 1B), BNST [F(1, 36) = 90.17, p < 0.001; Figure 1C), CA1
[F(1, 36) = 16.61, p < 0.001; Figure 1D], CIN [F(1, 36) = 4.85,
p < 0.05; Figure 1E], NACc [F(1, 36) = 23.28, p < 0.001;
Figure 1F]. Representative images for neuronal activation in the
CEA following saline or MA exposure in the day (AM) and night
(PM) are shown in Figure 1G.
Pattern 2. Brain Areas That Showed Only an
Effect of Time
Three brain regions showed significantly more c-Fos positive
cells in the light than dark period. A significant main effect
of time, but no significant effects of MA, was found for
the number of c-Fos cells in the SCN [F(1, 36) = 185.78,
p < 0.001; Figure 2A], VMH [F(1, 36) = 12.92, p <
0.001; Figure 2B], and DMH [F(1, 36) = 5.48, p = 0.02;
Figure 2C]. Representative images for neuronal activation in the
SCN following saline or MA exposure in the day and night
phases are shown in Figure 2D. There were trends toward
an effect of time in the ILC (p = 0.08, Figure 1A) and
CIN (p = 0.06, Figure 1E) but that did not reach statistical
significance.
FIGURE 2 | Brain areas that showed only an effect of time. The number of c-Fos immuno-positive cells is higher in the day than night in the SCN (A), VMH (B),
and DMH (C). Representative images for neuronal activation in the SCN following saline or MA exposure in the day and night are shown in (D). n = 10
mice/treatment/time period.
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Pattern 3. Brain Areas That Showed Effects of
Treatment and a Treatment × Time Interaction
Some regions showed only a profound increase in c-Fos positive
cells following MA in the day. A significant interaction between
treatment and time was found in the PVN [F(1, 36) = 26.51, p <
0.001; Figure 3A], PVT [F(1, 36) = 9.26, p < 0.01; Figure 3B],
and ARC [F(1, 36) = 90.17, p < 0.001; Figure 3C]. In the light
phase, the number of c-Fos positive cells was higher following
MA than saline exposure in the PVN (p < 0.001), PVT (p <
0.001), and ARC (p < 0.001). In the dark phase, the number
of c-Fos positive cells was only higher following MA than saline
exposure in the PVT (p = 0.028) but not in the PVN or ARC. In
the PVN, in addition to the MA × time interaction, there were
also main effects of MA [F(1, 36) = 38.09, p < 0.001] and time
[F(1, 36) = 12.89, p < 0.001; Figure 3A). Representative images
for neuronal activation in the PVN following saline or MA
exposure in the light and dark phases are shown in Figure 3D.
In addition to the MA × time interaction, there were also main
effects ofMA in the PVT [F(1, 36) = 50.24, p < 0.001; Figure 2B],
and ARC [F(1, 36) = 15.05, p < 0.001; Figure 2C]. As there
was a treatment × time interaction in these brain areas, we
also assessed whether for each treatment there was a significant
difference between neuronal activation in the light and dark
phase. In the PVN (p < 0.0001), PVT (p = 0.01), and ARC
(p = 0.03) neuronal activation following MA exposure was
significantly greater in the light than dark phase. In contrast,
in the ARC, neuronal activation following saline exposure was
significantly greater in the dark than the light phase (p < 0.01).
FIGURE 3 | Brain areas that showed effects of treatment and a treatment × time interaction. The increase in the number of c-Fos positive cells following MA
exposure is greater in the day than in the night in the PVN (A), PVT (B), and ARC (C). In these three brain regions there was a MA × time interaction. In the dark
phase, the number of c-Fos positive cells was only higher following MA than saline exposure in the PVT (p = 0.028) but not in the PVN or ARC. In the PVN
(p < 0.0001), PVT (p = 0.01), and ARC (p = 0.03) neuronal activation following MA exposure was significantly greater in the light than dark phase. In contrast, in the
ARC, neuronal activation following MA exposure was significantly greater in the dark than the light phase (p < 0.01). In the PVN (p = 0.12) and PVT (p = 0.20), there
was no difference in neuronal activation following saline exposure in the light and dark phase. Representative images for neuronal activation in the PVN following saline
or MA exposure in the day and night are shown in (D). n = 10 mice/treatment/time period.
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In the PVN (p = 0.12) and PVT (p =0.20), there was no difference
in neuronal activation following saline exposure in the light and
dark phase.
Pattern 4. Brain Areas That Showed Effects of
Treatment and Time
Two brain regions showed effects of treatment and time but no
treatment × time interaction. The CA3 showed main effects of
MA [F(1, 36) = 38.09, p < 0.001] and time [F(1, 36) = 30.32,
p < 0.001] but noMA× time interaction (Figure 4A). TheNACs
also showed main effects of MA [F(1, 36) = 23.28, p < 0.001] and
time [F(1, 36) = 5.20, p = 0.028] but no MA × time interaction
(Figure 4B). Representative images for neuronal activation in the
CA3 following saline orMA exposure in the light and dark phases
are shown in Figure 4C.
Pattern 5. Brain Areas That Showed No
Treatment or Time Effects or Treatment × Time
Interaction
Three brain regions showed neither overall effects of MA or time
or a MA × time interaction (Figure 5): the MEA (Figure 5A),
BLA (Figure 5B), and DG (Figure 5C). There was a trend toward
an interaction between MA and time in the MEA (p = 0.08) with
an increase in the number of c-Fos positive cells following MA
exposure in the day but decrease in the number of c-Fos positive
cells following MA exposure in the night but that did not reach
significance. Representative images for neuronal activation in the
DG following saline or MA exposure in the light and dark phases
are shown in Figure 5D.
c-Fos-AVP Dual-labeling
Analysis of the number of c-Fos/AVP dual labeled cells in the
PVN revealed comparable numbers in all four experimental
groups and no effect of MA treatment (Figure 6A; see Figure 6B
for a representative image of c-Fos/AVP double labeling). There
was no effect of MA treatment on the number of c-Fos/AVP dual
labeled cells in the SCN either [F(1, 12) = 0.16, p = 0.69, data not
shown].
Functional Connectivity Analysis
We inferred a measure of functional connectivity between
brain regions, following the general methodology introduced by
Schiltz et al. (2007). We started by computing the correlations
between all distinct brain regions; summing the absolute values
of these connectivity values resulted in a measure of functional
connectivity of each brain region. It is conceivable that spurious
FIGURE 4 | Brain areas that showed effects of treatment and time. In the CA3 (A) and NACs (B), MA and time affected the number of c-Fos positive cells and
no MA × time interaction was seen. Representative images for neuronal activation in the CA3 following saline or MA exposure in the day and night are shown in (C).
n = 10 mice/treatment/time period.
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FIGURE 5 | Brain areas that showed no treatment or time effects or a treatment × time interaction. There were no significant effects of MA, time, or an
interaction between MA and time in the MEA (A), BLA (B), and DG (C). There was a trend toward an interaction in the MEA (p = 0.08) but that did not reach
significance. Representative images for neuronal activation in the DG following saline or MA exposure in the day and night are shown in (D). n = 10
mice/treatment/time period.
correlations between these quantities could result in false
positives, or connectivity values that are due to chance. To guard
against this possibility, we employed a randomization procedure.
We randomized the order of the samples (N = 10, 000)
and we recomputed the connectivity values for each region
utilizing the randomized data. The connectivity values inferred
utilizing the correct sample order were compared against the
distribution of these random connectivity values and quantified
utilizing Z-scores. Significant values (Z > 2) were taken to signify
connectivity that is unlikely to arise by pure chance. Nearly all of
the regions examined, the connectivity values were significantly
higher than values derived from randomized data (see Table 2).
In particular, VMH appears highly connected following MA
exposure but not after saline.
Next, we directly tested the hypothesis that VMH connectivity
is significantly altered following exposure to MA. As detailed
in Methods, we employed a bootstrapping procedure which
involved combining the MA and saline data, randomly assigning
each sample to one of two mixed groups (N = 10, 000), and
computing the differences between these groups. Differences
between groups arranged in this manner are expected to be
small and to reflect spurious changes arising from pure chance.
Compared with this distribution of random differences, the
difference in VMH connectivity between the MA exposed and
saline exposed networks corresponds to a Z-score of 2.6 and a
bootstrap p-value. We illustrate these results in Figure 7.
For a majority of regions examined, the connectivity values
were significantly higher than values derived from randomized
data (see Table 2).
Next, we inquired whether exposure to MA disrupts the
pattern of connectivity between brain regions. The most
affected region was the VMH, where the difference in
Frontiers in Neuroscience | www.frontiersin.org 8 September 2015 | Volume 9 | Article 326
Zuloaga et al. Methamphetamine and the ventromedial hypothalamus
connectivity between the MA exposed and saline exposed
networks corresponds to a Z-score of 2.6. We illustrate these
results in Figure 7.
Discussion
The results of this study demonstrated that, within the limited
number of the brain areas analyzed, there are at least five distinct
patterns of neuronal activation (Table 1): (1) brain areas such as
the CEA, BNST, CA1, CIN, and NACc that show only an effect
of treatment. In the CA1, more neuronal activation following
exposure to saline is seen in the dark than light phase (p < 0.05)
and there was a trend toward such an effect in the ILC (p =
0.054). This circadian-dependent effect was not seen in the CEA,
FIGURE 6 | (A) Similar c-Fos/AVP dual-labeling in the PVN following MA
exposure in the AM and PM. Mice treated with MA in the day and night
showed no increase in c-Fos/AVP-ir cells in the PVN compared to
saline-treated mice. n = 10 mice/treatment/time period. (B) Representative
panel of c-Fos (red) and AVP (green) from a mouse treated with MA in the AM
is shown.
BNST, and NACc; (2) brain areas such as the SCN and VMH
that showed only an effect of time; (3) brain areas such as the
PVN, PVT, and ARC, which show an effect of treatment and a
treatment × time interaction with a more profound activation
during the light compared to the dark phase; (4) brain areas
such as CA3 and NACs which show effects of treatment and
time; and (5) brain areas such as MEA, BLA, and DG that show
no neuronal activation following MA exposure and comparable
neuronal activation in the light and dark phases. We recognize
that in brain areas with elevated basal levels of c-Fos no effects
might have been seen due to a potential ceiling effect. The pattern
of neuronal activation following MA exposure that shows more
profound activation during the light compared to the dark phase
highlights the importance of time of drug taking (for review, see
Hasler et al., 2012).
The difference in connectivity between the MA and saline
exposed networks was the greatest in the VMH. The enhanced
functional connectivity between the VMH and the PVN, BLA,
and MEA following MA exposure is consistent with a stress
response (Dunn, 1987; Sánchez et al., 1995; Walker and Davis,
1997; Fendt et al., 2005). Consistent with this notion, MA
activates the HPA axis (Williams et al., 2000; Acevedo et al., 2008;
Zuloaga et al., 2014) and chronic stress augments the acute and
long-term effects of MA (Matuszewich and Yamamoto, 2004).
In brain areas like the PVN, the circadian-dependent pattern
of activation following MA exposure resembles that seen for
stress-induced activation of the HPA axis. The pattern of HPA
axis activation shows low baseline stress hormone levels and a
stronger stress response in the early light period, compared to a
high baseline and reduced stress response in the late light period,
close to the onset of the dark period (Raber et al., 2000).
Within the limitations of the current study, AVP does not
seem to play a significant role in the MA-induced neuronal
activation in the PVN in the light phase. However, we recognize
that AVP might play role in the effect of MA at other time points
or in other brain areas, such as the VMH in which AVP was
shown to provide a diurnal rhythm of stimulatory input in rats
(Kalsbeek et al., 1996). Future efforts are warranted to determine
the role of AVP in MA-induced circadian-dependent neuronal
activation.
When neuronal activation was analyzed in individual brain
regions, MA exposure did not affect neuronal activation in the
VMH in either the light or dark phase compared to saline
exposure, a pattern similar to that seen in the SCN. However,
the functional connectivity data with a profound difference
TABLE 2 | Region connectivity Z-scores in brains of methamphetamine (MA) and saline (SA) treated micea.
SCN PVN PVT CEA BLA MEA DG CA1 CA3 ILC ARC VMH DMH BNST CIN NAC core NACshell
MA 2.59 3.17 1.15 2.23 1.65 1.84 3.17 2.29 2.61 2.67 1.89 2.65 3.52 0.21 1.65 1.32 2.37
SA 2.63 1.85 1.15 0.72 3.23 3.58 1.61 3.11 3.55 5.47 4.18 0.27 2.06 2.46 2.54 3.33 3.83
p 0.50 0.21 0.49 0.14 0.81 0.84 0.18 0.44 0.71 0.95 0.83 0.008 0.25 0.94 9.69 0.78 0.81
aEach region connectivity value is compared to connectivity values from randomized samples. A majority of the regions have Z-scores above 2 and p-values < 0.05 for at least one of
the conditions.
There is a large difference in connectivity between MA and saline for the VMH (indicated in bold). This difference was subsequently determined to be statistically significant by a
bootstrapping procedure as described in the results section.
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FIGURE 7 | Patterns of connectivity of the VMH region in MA exposed (A) and MA naïve (B) mice. The thickness and color of the edges (red for positive and
blue for negative) corresponds to the strength and direction (positive or negative) of the correlations. VMH displays changes in correlations with a number of other
regions; the combined effects of these changes is quantified as change in connectivity.
in connectivity between the MA exposed and saline exposed
networks might suggest a role for VMH in MASCO. Consistent
with this hypothesis, the VMH is involved in synchronization
of rhythms to periodic feeding (Inouye, 1983) and in circadian
rhythms of circulating levels of insulin, glucose, and triglycerides
(Kraeuchi et al., 1985; Egawa et al., 1993; Mitsushima et al.,
1994). However, we recognize that a brain region involved in
MASCO might show a response in neuronal activation following
MA exposure in either the light and/or dark phases and that at
present too little is known about MASCO to draw any definite
conclusion.
The alterations in coordinated activity in brain following MA
exposure might play an important role in the detrimental effects
of MA. In addition to environmental factors, genetic factors also
play an important role in the strengths of network connectivity
(Glahn et al., 2010; Fornito et al., 2011) and might play a
role in modulating individual susceptibility to effects of MA.
Recently, synaptic genes and polymorphisms in these genes were
shown to be particularly important in determining functional
connectivity in brain and to be associated with resting state
measures of functional magnetic resonance imaging (fMRI) and
neurological diseases (Richiardi et al., 2015). Future efforts are
warranted to determine how the connectivity data revealed using
c-Fos immunoreactivty in this study compare to MRI measures
following MA exposure.
In summary, the data of this study show distinct patterns
of neuronal activation following MA exposure. In several
brain areas, neuronal activation following exposure to MA
is stronger in the light than the dark phase highlighting
the importance of considering circadian periods in defining
experimental conditions and understanding the mechanisms
underlying detrimental effects of MA exposure to brain function.
The enhanced functional connectivity between the VMH and
areas like the PVN, BLA and MEA following MA exposure is
consistent with a stress response. Future efforts are warranted to
determine the role of the VMH in effects of MA on the brain.
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